Mukka Proteins Limited — Others, 14-11-2024: Monitoring Agency Report

Mukka Proteins Limited has reported the Monitoring Agency's assessment concerning the use of proceeds from its IPO for the quarter ended September 30, 2024. The report from ICRA Limited indicates no material deviations from the planned use of funds, with the total utilized amount reaching ₹178.356 crore against a projected ₹185.808 crore. The monitoring agency validated that the proceeds are being employed correctly according to the offering document. This transparency may foster investor confidence, suggesting a positive outlook as the company adheres to its strategic financial commitments and projects stability in the long run.